Skip to main content

Radiation Oncology

See Also:
The Beamline Bulletin

Expert Gallery Profiles

Submissions from 2019 2019

MGMT promoter methylation status testing to guide therapy for glioblastoma: refining the approach based on emerging evidence and current challenges, Minesh Mehta

Stereotactic radiosurgery with concurrent lapatinib is associated with improved local control for HER2-positive breast cancer brain metastases, Rupesh Kotecha

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA), Michael Chuong and Minesh Mehta

CMET-06. AN ANALYSIS OF RESPONSE ENDPOINTS FOR BRAIN METASTASIS PATIENTS TREATED WITH STEREOTACTIC RADIOSURGERY AND PD(L)-1 INHIBITORS, Rupesh Kotecha

Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes, Minesh Mehta

Low-Grade Glioma Radiotherapy Treatment and Trials, Minesh Mehta

Preoperative Vs Postoperative Radiosurgery For Resected Brain Metastases: A Review, Minesh Mehta

Submissions from 2018 2018

The Case for Proton Beam Therapy, Michael Chuong

Postoperative Management of Resected Brain Metastases: When Can Radiotherapy Be Deferred?, Minesh Mehta and Rupesh Kotecha

Evaluation of Proton Therapy Accuracy Using a PMMA Phantom and PET Prediction Module, Wen Hsi

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool, Minesh Mehta

Recent advances in managing brain metastasis, Rupesh Kotecha and Minesh Mehta

Dosimetric Impact of Large Displacement of the Metal Port of the Tissue Expander in Intensity Modulated Proton Therapy, Jen Yu, Jaafar Bennouna, and Minesh Mehta

Onco-metabolism: defining the prognostic significance of obesity and diabetes in women with brain metastases from breast cancer, Minesh Mehta

Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study, Minesh Mehta

Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing, Rupesh Kotecha

Ten-Year Outcomes and Toxicity with Moderately Hypofractionated (70 Gy in 28 fractions) Intensity-Modulated Radiation Therapy for Localized Prostate Cancer, Rupesh Kotecha

Treatment recommendations for elderly patients with newly diagnosed glioblastoma lack worldwide consensus, Minesh Mehta

What is the evidence for the clinical value of SBRT in cancer of the cervix?, Minesh Mehta

Proton therapy patterns of care among pediatric and adult patients with CNS tumors, Rupesh Kotecha

Association of MGMT Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide: An Analysis From the NRG Oncology/RTOG 0424 Trial, Minesh Mehta

Correlation of radiation dose and activity with clinical outcomes in metastatic colorectal cancer after selective internal radiation therapy using yttrium-90 resin microspheres, Michael Chuong

Effect of Switching Systemic Treatment After Stereotactic Radiosurgery for Oligoprogressive, Metastatic Renal Cell Carcinoma, Rupesh Kotecha

Proton beam therapy for gastrointestinal cancers: past, present, and future, Matthew Hall and Michael Chuong

Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order, Minesh Mehta

Combining immunotherapy with radiation therapy in thoracic oncology, Michael Chuong

Omitting radiosurgery in melanoma brain metastases: a drastic and dangerous de-escalation, Minesh Mehta

Pencil beam scanning versus passively scattered proton therapy for unresectable pancreatic cancer, Michael Chuong, Man Yam, and Minesh Mehta

Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases, Minesh Mehta

Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539, Minesh Mehta

Short delay in initiation of radiotherapy for patients with glioblastoma- effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database, Minesh Mehta

(OA13) Stereotactic Radiosurgery and Concurrent Targeted Therapy: Improving the Response Rate for Breast Cancer Brain Metastasis, Rupesh Kotecha

Prognostic and predictive factors in patients with brain metastases from solid tumors: A review of published nomograms, Minesh Mehta

An evaluation of the stability of image quality parameters of Elekta X-ray volume imager and iViewGT imaging systems, Alonso Gutierrez

Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations, Minesh Mehta

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: Results of NRG Oncology RTOG 0913, Minesh Mehta

Brain Metastases in Lung Cancer With Targetable Mutations-Reply, Minesh Mehta

Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial, Michael Chuong

Modeling the target dose fall-off in IMRT and VMAT planning techniques for cervical SBRT, Alonso Gutierrez

The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists, Minesh Mehta

Control versus cognition: the changing paradigm of adjuvant therapy for resected brain metastasis, Minesh Mehta

Temozolomide, sirolimus and chloroquine is a new therapeutic combination that synergizes to disrupt lysosomal function and cholesterol homeostasis in GBM cells, Minesh Mehta

Adaptive planning and toxicities of uniform scanning proton therapy for lung cancer patients, Suresh Rana

Clinical trial design for local therapies for brain metastases: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group, Minesh Mehta

Dosimetric Evaluation of Pinnacle's Automated Treatment Planning Software to Manually Planned Treatments, Alonso Gutierrez

Early Objective Response as a Prognosticator for Final Objective Response and Survival following SRS for Brain Metastases Treated with Concurrent Systemic Therapy, Rupesh Kotecha

Improving the therapeutic index for nonoperable esophageal cancer patients with modern radiation technologies, Michael Chuong and Matthew Hall

Mid/Distal Esophageal Cancer and Gastroesophageal Junction Cancer (Siewert Type I and II), Michael Chuong

Phase I study of sorafenib and tipifarnib for recurrent glioblastoma: NABTC 05-02, Minesh Mehta

Submissions from 2017 2017

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA), Minesh Mehta

Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee, Michael Chuong

MBA degree is needed for leadership roles in Medical Physics profession, Alonso Gutierrez

Comparison of initial patient setup accuracy between surface imaging and three point localization: A retrospective analysis, Alonso Gutierrez

Multi-institutional external validation of a novel glioblastoma prognostic nomogram incorporating MGMT methylation, Minesh Mehta

State of the art: the evolving role of RT in combined modality therapy for GBM, Minesh Mehta

The role of radiation in treating glioblastoma: here to stay, Minesh Mehta

The Changing Role of Whole-Brain Radiotherapy: Demise or Time for Selective Usage?, Minesh Mehta

The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases, Minesh Mehta

A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients, Michael Chuong and Minesh Mehta

A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas, Minesh Mehta

Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation, Minesh Mehta

The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings, Michael Chuong

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525, Minesh Mehta

Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer, Minesh Mehta and Michael Chuong

Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529, Andre Abitbol

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825, Minesh Mehta

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria, Minesh Mehta

Cost-effectiveness of prophylactic cranial irradiation with hippocampal avoidance in limited stage small cell lung cancer, Minesh Mehta

Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients, Minesh Mehta

Dosimetric and radiobiological impact of intensity modulated proton therapy and RapidArc planning for high-risk prostate cancer with seminal vesicles, Suresh Rana

Establishing Evidence-Based Indications for Proton Therapy: An Overview of Current Clinical Trials, Minesh Mehta

Multi-Institutional Experience of Stereotactic Ablative Radiation Therapy for Stage I Small Cell Lung Cancer, Minesh Mehta

Radiation Therapy for Liver Tumors: The State-of-the-art, Miguel Perez and Michael Chuong

Submissions from 2016 2016

Reply to M.C. Chamberlain, Minesh Mehta

Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study, Minesh Mehta

Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer, Minesh Mehta

Clinical outcomes and toxicities of proton radiotherapy for gastrointestinal neoplasms: a systematic review, Minesh Mehta

Stereotactic Radiosurgery for Treatment of Brain Metastases, Minesh Mehta

International Medical Graduates in Radiation Oncology: Historical Trends and Comparison With Other Medical Specialties, Minesh Mehta

Clinical ramifications of "genomic staging" of low-grade gliomas, Minesh Mehta

An overview of modern proton therapy, Minesh Mehta

HPV-Associated Oropharyngeal Cancer: Changing Treatment Paradigm & Prognosis, Andre Abitbol

Submissions from 2012 2012

Accelerated partial breast irradiation is safe and effective using intensity-modulated radiation therapy in selected early-stage breast cancer, Alan Lewin, Robert Derhagopian, Andre Abitbol, D Jay Wieczorek, Vivek Mishra, and Lourdes Moreno

Submissions from 2007 2007

Treatment of early non-small cell lung cancer, stage IA, by image-guided robotic stereotactic radioablation--CyberKnife, William Brown, Alan Lewin, and Andre Abitbol

Submissions from 2005 2005

Phase II study of tolerance and efficacy of hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (taxol) and amifostine (ethyol) in head and neck squamous cell carcinomas: A-3 protocol, Andre Abitbol, Alan Lewin, and Michael Troner

Quality-of-life assessment after hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in inoperable and/or unresectable head and neck squamous cell carcinoma, Andre Abitbol, Alan Lewin, and Michael Troner

Submissions from 2002 2002

Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol, Andre Abitbol, Alan Lewin, Michael Troner, and Maria-Amelia Rodrigues

Submissions from 1996 1996

Management of stage I-B, II-A, and II-B carcinoma of the cervix with high-dose-rate brachytherapy: initial results of an institutional clinical trial, Andre Abitbol and Alan Lewin

Submissions from 1992 1992

Stereotactic radiosurgery: dose-volume analysis of linear accelerator techniques, Christopher Serago, Alan Lewin, Andre Abitbol, Sergio Gonzalez-Arias, and Victor Marcial-Vega

Submissions from 1991 1991

Scattering effects on the dosimetry of iridium-192, Christopher Serago, Andre Abitbol, Alan Lewin, and Victor Marcial-Vega

Improved linac dose distributions for radiosurgery with elliptically shaped fields, Christopher Serago, Alan Lewin, Sergio Gonzalez-Arias, Andre Abitbol, and Victor Marcial-Vega

Stereotactic target point verification of an X ray and CT localizer, Christopher Serago, Alan Lewin, Sergio Gonzalez-Arias, and Andre Abitbol